Kesin Pharma Corporation
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 3874 Tampa Rd Ste 103,, Oldsmar, Florida (FL) 34677-3126, United States (USA)
- Operations here
- labelpackrepack
- FDA identifiers
- FEI 3016965788 · DUNS 117447816
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2024-01-19
Drugs this plant is listed as making
12 distinct drugs across 15 products name this site in their FDA label.
- AtovaquoneKesin Pharma
- Chlorhexidine Gluconate, 0.12% Oral RinseKesin Pharma Corporation
- Fosfomycin TromethamineKesin Pharma Corporation
- GabapentinKesin Pharma Corporation
- LacosamideKesin Pharma Corporation
- Lactulose Solution USP, 10 g/15 mLKesin Pharma Corporation
- NystatinKesin Pharma Corporation
- Phenobarbital OralKesin Pharma Corporation
- prednisoLONE sodium phosphateKesin Pharma
- SucralfateKesin Pharma Corporation
- Sulfamethoxazole and TrimethoprimKesin Pharma
- Valproic AcidKesin Pharma Corporation
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.